Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.19
(0.53%)
HKD 0.19
(0.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 917.44 Million HKD | -22.95% |
| 2022 | 1.19 Billion HKD | 26.43% |
| 2021 | 941.83 Million HKD | -5.01% |
| 2020 | 991.47 Million HKD | 25.53% |
| 2019 | 789.85 Million HKD | 11.31% |
| 2018 | 709.58 Million HKD | 26.16% |
| 2017 | 562.43 Million HKD | 17.98% |
| 2016 | 476.73 Million HKD | 16.91% |
| 2015 | 407.79 Million HKD | 14.88% |
| 2014 | 354.95 Million HKD | 579.63% |
| 2013 | 52.22 Million HKD | 138.78% |
| 2012 | 21.87 Million HKD | 98.13% |
| 2011 | 11.04 Million HKD | 0.0% |
| 2010 | - HKD | 0.0% |
| 2009 | - HKD | 0.0% |
| 2008 | - HKD | -100.0% |
| 2007 | 674.14 Million HKD | 10.0% |
| 2006 | 612.87 Million HKD | 10.33% |
| 2005 | 555.51 Million HKD | 9.47% |
| 2004 | 507.44 Million HKD | -16.81% |
| 2003 | 609.97 Million HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 995.8 Million HKD | -4.39% |
| 2023 Q1 | 1.04 Billion HKD | -12.53% |
| 2023 FY | 917.44 Million HKD | -22.95% |
| 2023 Q4 | 917.44 Million HKD | -12.97% |
| 2023 Q3 | 1.05 Billion HKD | 5.87% |
| 2022 FY | 1.19 Billion HKD | 26.43% |
| 2022 Q3 | 1.23 Billion HKD | 16.84% |
| 2022 Q4 | 1.19 Billion HKD | -3.63% |
| 2022 Q2 | 1.05 Billion HKD | -3.99% |
| 2022 Q1 | 1.1 Billion HKD | 16.94% |
| 2021 Q1 | 910.37 Million HKD | -8.18% |
| 2021 Q2 | 864.55 Million HKD | -5.03% |
| 2021 Q3 | 985.72 Million HKD | 14.01% |
| 2021 Q4 | 941.83 Million HKD | -4.45% |
| 2021 FY | 941.83 Million HKD | -5.01% |
| 2020 FY | 991.47 Million HKD | 25.53% |
| 2020 Q4 | 991.47 Million HKD | -4.32% |
| 2020 Q2 | 875.88 Million HKD | -4.76% |
| 2020 Q3 | 1.03 Billion HKD | 18.31% |
| 2020 Q1 | 919.62 Million HKD | 16.43% |
| 2019 Q4 | 789.85 Million HKD | -5.23% |
| 2019 Q2 | 770.04 Million HKD | -6.42% |
| 2019 FY | 789.85 Million HKD | 11.31% |
| 2019 Q1 | 822.9 Million HKD | 15.97% |
| 2019 Q3 | 833.42 Million HKD | 8.23% |
| 2018 Q2 | 599.62 Million HKD | -13.74% |
| 2018 Q3 | 755.45 Million HKD | 25.99% |
| 2018 Q4 | 709.58 Million HKD | -6.07% |
| 2018 FY | 709.58 Million HKD | 26.16% |
| 2018 Q1 | 695.16 Million HKD | 23.6% |
| 2017 Q4 | 562.43 Million HKD | -10.45% |
| 2017 Q3 | 628.07 Million HKD | 24.29% |
| 2017 Q2 | 505.32 Million HKD | -11.5% |
| 2017 Q1 | 570.96 Million HKD | 19.76% |
| 2017 FY | 562.43 Million HKD | 17.98% |
| 2016 Q3 | 542.37 Million HKD | 26.71% |
| 2016 Q4 | 476.73 Million HKD | -12.1% |
| 2016 Q1 | 493.68 Million HKD | 21.06% |
| 2016 FY | 476.73 Million HKD | 16.91% |
| 2016 Q2 | 428.04 Million HKD | -13.3% |
| 2015 Q2 | 369.85 Million HKD | -15.07% |
| 2015 Q3 | 473.43 Million HKD | 28.01% |
| 2015 Q4 | 407.79 Million HKD | -13.86% |
| 2015 Q1 | 435.49 Million HKD | 22.69% |
| 2015 FY | 407.79 Million HKD | 14.88% |
| 2014 Q3 | 420.59 Million HKD | 36.81% |
| 2014 FY | 354.95 Million HKD | 579.63% |
| 2014 Q1 | 307.44 Million HKD | 488.65% |
| 2014 Q4 | 354.95 Million HKD | -15.61% |
| 2014 Q2 | 307.44 Million HKD | 0.0% |
| 2013 Q3 | 50.17 Million HKD | 0.0% |
| 2013 Q4 | 52.22 Million HKD | 4.08% |
| 2013 FY | 52.22 Million HKD | 138.78% |
| 2013 Q1 | 21.87 Million HKD | -40.81% |
| 2013 Q2 | 50.17 Million HKD | 129.41% |
| 2012 FY | 21.87 Million HKD | 98.13% |
| 2012 Q2 | - HKD | -100.0% |
| 2012 Q1 | 11.04 Million HKD | 0.0% |
| 2012 Q3 | 14.18 Million HKD | 0.0% |
| 2012 Q4 | 36.95 Million HKD | 160.54% |
| 2011 FY | 11.04 Million HKD | 0.0% |
| 2011 Q3 | - HKD | 0.0% |
| 2011 Q1 | - HKD | 0.0% |
| 2010 Q3 | - HKD | 0.0% |
| 2010 Q1 | - HKD | 0.0% |
| 2010 FY | - HKD | 0.0% |
| 2009 FY | - HKD | 0.0% |
| 2008 FY | - HKD | -100.0% |
| 2007 FY | 674.14 Million HKD | 10.0% |
| 2006 FY | 612.87 Million HKD | 10.33% |
| 2005 FY | 555.51 Million HKD | 9.47% |
| 2004 FY | 507.44 Million HKD | -16.81% |
| 2003 FY | 609.97 Million HKD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 186.28 Million HKD | -392.492% |
| China Overseas Nuoxin International Holdings Limited | 49.93 Million HKD | -1737.36% |
| Prosperous Future Holdings Limited | 20.89 Million HKD | -4290.969% |
| Huasheng International Holding Limited | 338.39 Million HKD | -171.116% |
| Fourace Industries Group Holdings Limited | 3.24 Million HKD | -28216.327% |
| Evergreen Products Group Limited | 615 Million HKD | -49.178% |
| EC Healthcare | 1.6 Billion HKD | 42.792% |
| Ming Fai International Holdings Limited | 57.56 Million HKD | -1493.873% |
| Blue Moon Group Holdings Limited | 158.89 Million HKD | -477.39% |
| SuperRobotics Holdings Limited | 138.44 Million HKD | -562.686% |
| Takbo Group Holdings Limited | 11.53 Million HKD | -7856.37% |
| Hyfusin Group Holdings Limited | 18.36 Million HKD | -4896.183% |